MARIO LOPEZ ESQUEDA: Open Payments
NPI 1154891430 · BRAWLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$459 in 19 payments from 7 companies in 2025. Trend: 2023 $349 · 2024 $829 · 2025 $459
Food & beverage: $459
| Company | Payments | Amount |
|---|---|---|
| MDD US Operations, LLC | 8 | $203 |
| Neurocrine BioSciences, Inc. | 3 | $82 |
| Otsuka America Pharmaceutical, Inc. | 3 | $75 |
| Amneal Pharmaceuticals LLC | 2 | $42 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
| Neurelis, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $14 |
Products named: Gocovri, INGREZZA, REXULTI, Qelbree, CREXONT, JOURNAVX, VALTOCO, ELIQUIS.
Industry payments across CA — which companies pay providers there.
